Patents by Inventor Sophia Park

Sophia Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230186115
    Abstract: Systems, devices, and methods for data collection and development as well as providing user interaction policies are provided. In one embodiment, a method includes collecting contextual data for a first subset of a plurality of users. The method further includes generating a first set of contextual profiles for the first subset of the plurality of users based on the collected contextual data. Additionally, the method includes training one or more imputation models to develop the contextual data for the second subset of the plurality of users. The method also includes generating the contextual data for the second subset of the plurality of users using the one or more imputation models. Further, the method includes generating a second set of contextual profiles for the second subset of the plurality of users based on the generated contextual data for the second subset of the plurality of users.
    Type: Application
    Filed: December 14, 2022
    Publication date: June 15, 2023
    Inventors: Afshan A. KLEINHANZL, Alexander Michael DIENER, Adam G. NOAR, JR., Stacey Lynne FISCHER, Chad M. PATTERSON, Carly Rose OLSON, Michiko Araki KELLEY, Amit Premal JOSHIPURA, Spencer Troy FRANK, Qi AN, Abdulrahman JBAILY, Sophia PARK, Justin Yi-Kai LEE, Joost Herman VAN DER LINDEN, Mark DERDZINSKI
  • Publication number: 20220409606
    Abstract: The present disclosure relates to methods and compounds for promoting anabolic pathways in neuronal cells leading to improved neuronal survival. In particular, the present disclosure relates to inhibiting PHD to promote glycolysis and neuronal survival in a variety of neurodegenerative conditions such as retinitis pigmentosa.
    Type: Application
    Filed: June 15, 2018
    Publication date: December 29, 2022
    Inventors: Stephen H. Tsang, Xuan Cui, Christine Xu, Karen Sophia Park
  • Patent number: 6479548
    Abstract: Compound of formula I activate the insulin receptor kinase. Pharmaceutical compositions comprising the compounds, and methods of treatment of hyperglycemia and other diseases involving imbalance of glucose levels, especially for the treatment of type II diabetes, by administering these compounds to mammalian hosts, and processes for their preparation, are also described.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: November 12, 2002
    Assignee: Telik, Inc.
    Inventors: John Patterson, Sophia Park, Robert T. Lum, Wayne R. Spevak